Evidence map›Paper›PMID 33313031›Full record

ArticleFrontiers in pediatrics2020

Corrigendum: Clinical Protocol for a Longitudinal Cohort Study Employing Systems Biology to Identify Markers of Vaccine Immunogenicity in Newborn Infants in The Gambia and Papua New Guinea.

Olubukola T Idoko, Kinga K Smolen, Oghenebrume Wariri, Abdulazeez Imam, Casey P Shannon, Tida Dibassey, Joann Diray-Arce, Alansana Darboe, Julia Strandmark, Rym Ben-Othman and 16 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pediatrics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors.

Olubukola T IdokoVaccines and Immunity Theme, Medical Research Council Unit the Gambia at London School of Hygiene and Tropical Medicine, Fajara, Gambia.
Kinga K SmolenPrecision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, United States.
Oghenebrume WaririVaccines and Immunity Theme, Medical Research Council Unit the Gambia at London School of Hygiene and Tropical Medicine, Fajara, Gambia.
Abdulazeez ImamVaccines and Immunity Theme, Medical Research Council Unit the Gambia at London School of Hygiene and Tropical Medicine, Fajara, Gambia.
Casey P ShannonPROOF Centre of Excellence, Vancouver, BC, Canada.
Tida DibasseyVaccines and Immunity Theme, Medical Research Council Unit the Gambia at London School of Hygiene and Tropical Medicine, Fajara, Gambia.
Joann Diray-ArcePrecision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, United States.
Alansana DarboeVaccines and Immunity Theme, Medical Research Council Unit the Gambia at London School of Hygiene and Tropical Medicine, Fajara, Gambia.
Julia StrandmarkVaccines and Immunity Theme, Medical Research Council Unit the Gambia at London School of Hygiene and Tropical Medicine, Fajara, Gambia.
Rym Ben-OthmanDepartment of Pediatrics, BC Children's Hospital, University of British Columbia, Vancouver, BC, Canada.
Oludare A OdumadePrecision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, United States.
Kerry McEnaneyPrecision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, United States.
Nelly AmenyogbeWesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Nedlands, WA, Australia.
William S PomatPapua New Guinea Institute of Medical Research, Goroka, Papua New Guinea.
Simon van HarenPrecision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, United States.
Guzmán Sanchez-SchmitzPrecision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, United States.
Ryan R BrinkmanBC Cancer Agency, Vancouver, BC, Canada.
Hanno SteenPrecision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, United States.
Robert E W HancockDepartment of Microbiology & Immunology, University of British Columbia, Vancouver, BC, Canada.
Scott J TebbuttPROOF Centre of Excellence, Vancouver, BC, Canada.
Peter C RichmondWesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Nedlands, WA, Australia.
Anita H J van den BiggelaarWesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Nedlands, WA, Australia.
Tobias R KollmannWesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Nedlands, WA, Australia.
Ofer LevyPrecision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, United States.
Al OzonoffPrecision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, United States.
Beate KampmannVaccines and Immunity Theme, Medical Research Council Unit the Gambia at London School of Hygiene and Tropical Medicine, Fajara, Gambia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fped.2020.00197.].

Indexed as

immunogenicitymarkersnewbornOMICSsystems biologyvaccine

Identifiers

PMID33313031
PMCPMC7707081

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.